CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 3.110
  • +0.210+7.24%
15min DelayMarket Closed Dec 24 13:00 ET
218.66MMarket Cap-8.18P/E (TTM)

NervGen Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
109.51%7.16M
25.80%6M
5.36%4.97M
-22.79%17.78M
-28.15%4.87M
-30.62%3.42M
-24.45%4.77M
-5.75%4.72M
79.73%23.03M
63.60%6.78M
Selling and administrative expenses
9.33%2.79M
-31.83%2.2M
18.12%1.97M
51.96%9.63M
29.91%2.18M
48.98%2.55M
108.99%3.23M
19.20%1.67M
6.75%6.34M
4.10%1.68M
-General and administrative expense
9.33%2.79M
-31.83%2.2M
18.12%1.97M
51.96%9.63M
29.91%2.18M
48.98%2.55M
108.99%3.23M
19.20%1.67M
6.75%6.34M
4.10%1.68M
Research and development costs
421.08%4.36M
150.19%3.8M
-1.65%2.97M
-51.57%8.05M
-47.48%2.67M
-73.71%837.57K
-68.00%1.52M
-16.11%3.02M
141.77%16.61M
100.60%5.08M
Depreciation amortization depletion
-97.19%703
-95.60%1.08K
0.17%24.36K
34.36%98.57K
1.47%24.67K
2.89%25.02K
3.26%24.56K
2,467.69%24.32K
3,471.81%73.37K
3,057.92%24.32K
-Depreciation and amortization
-97.19%703
-95.60%1.08K
0.17%24.36K
34.36%98.57K
1.47%24.67K
2.89%25.02K
3.26%24.56K
2,467.69%24.32K
3,471.81%73.37K
3,057.92%24.32K
Operating profit
-109.51%-7.16M
-25.80%-6M
-5.36%-4.97M
22.79%-17.78M
28.15%-4.87M
30.62%-3.42M
24.45%-4.77M
5.75%-4.72M
-79.73%-23.03M
-63.60%-6.78M
Net non-operating interest income (expenses)
78.45%243.68K
111.24%294.88K
-32.00%102.95K
275.63%550.07K
42.47%122.55K
130.34%136.55K
316.28%139.59K
773.19%151.39K
-1,164.70%-313.2K
569.88%86.01K
Non-operating interest income
78.45%243.68K
111.24%294.88K
-32.00%102.95K
173.13%550.07K
42.47%122.55K
111.67%136.55K
316.28%139.59K
773.19%151.39K
584.62%201.4K
569.88%86.01K
Non-operating interest expense
----
----
----
--0
----
----
----
----
--514.6K
--0
Other net income (expenses)
264.86%1.69M
-1,504.97%-2.12M
1,853.67%2.52M
-297.08%-5.16M
-608.91%-3.86M
-154.49%-1.02M
-238.73%-132.12K
-840.57%-143.77K
4,636.56%2.62M
5,889.78%757.77K
Gain on sale of security
264.86%1.69M
-1,504.97%-2.12M
1,853.67%2.52M
-297.08%-5.16M
-608.91%-3.86M
-154.49%-1.02M
-238.73%-132.12K
-840.57%-143.77K
4,636.56%2.62M
5,889.78%757.77K
Income before tax
-21.46%-5.23M
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
Income tax
Earnings from equity interest net of tax
Net income
-21.46%-5.23M
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
Net income continuous operations
-21.46%-5.23M
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
Noncontrolling interests
Net income attributable to the company
-21.46%-5.23M
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-21.46%-5.23M
-64.34%-7.83M
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
Diluted earnings per share
0.00%-0.07
-37.50%-0.11
50.00%-0.04
2.56%-0.38
-50.00%-0.15
-16.67%-0.07
38.46%-0.08
27.27%-0.08
-21.88%-0.39
-11.11%-0.1
Basic earnings per share
0.00%-0.07
-37.50%-0.11
50.00%-0.04
2.56%-0.38
-50.00%-0.15
-16.67%-0.07
38.46%-0.08
27.27%-0.08
-21.88%-0.39
-11.11%-0.1
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 109.51%7.16M25.80%6M5.36%4.97M-22.79%17.78M-28.15%4.87M-30.62%3.42M-24.45%4.77M-5.75%4.72M79.73%23.03M63.60%6.78M
Selling and administrative expenses 9.33%2.79M-31.83%2.2M18.12%1.97M51.96%9.63M29.91%2.18M48.98%2.55M108.99%3.23M19.20%1.67M6.75%6.34M4.10%1.68M
-General and administrative expense 9.33%2.79M-31.83%2.2M18.12%1.97M51.96%9.63M29.91%2.18M48.98%2.55M108.99%3.23M19.20%1.67M6.75%6.34M4.10%1.68M
Research and development costs 421.08%4.36M150.19%3.8M-1.65%2.97M-51.57%8.05M-47.48%2.67M-73.71%837.57K-68.00%1.52M-16.11%3.02M141.77%16.61M100.60%5.08M
Depreciation amortization depletion -97.19%703-95.60%1.08K0.17%24.36K34.36%98.57K1.47%24.67K2.89%25.02K3.26%24.56K2,467.69%24.32K3,471.81%73.37K3,057.92%24.32K
-Depreciation and amortization -97.19%703-95.60%1.08K0.17%24.36K34.36%98.57K1.47%24.67K2.89%25.02K3.26%24.56K2,467.69%24.32K3,471.81%73.37K3,057.92%24.32K
Operating profit -109.51%-7.16M-25.80%-6M-5.36%-4.97M22.79%-17.78M28.15%-4.87M30.62%-3.42M24.45%-4.77M5.75%-4.72M-79.73%-23.03M-63.60%-6.78M
Net non-operating interest income (expenses) 78.45%243.68K111.24%294.88K-32.00%102.95K275.63%550.07K42.47%122.55K130.34%136.55K316.28%139.59K773.19%151.39K-1,164.70%-313.2K569.88%86.01K
Non-operating interest income 78.45%243.68K111.24%294.88K-32.00%102.95K173.13%550.07K42.47%122.55K111.67%136.55K316.28%139.59K773.19%151.39K584.62%201.4K569.88%86.01K
Non-operating interest expense --------------0------------------514.6K--0
Other net income (expenses) 264.86%1.69M-1,504.97%-2.12M1,853.67%2.52M-297.08%-5.16M-608.91%-3.86M-154.49%-1.02M-238.73%-132.12K-840.57%-143.77K4,636.56%2.62M5,889.78%757.77K
Gain on sale of security 264.86%1.69M-1,504.97%-2.12M1,853.67%2.52M-297.08%-5.16M-608.91%-3.86M-154.49%-1.02M-238.73%-132.12K-840.57%-143.77K4,636.56%2.62M5,889.78%757.77K
Income before tax -21.46%-5.23M-64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M
Income tax
Earnings from equity interest net of tax
Net income -21.46%-5.23M-64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M
Net income continuous operations -21.46%-5.23M-64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M
Noncontrolling interests
Net income attributable to the company -21.46%-5.23M-64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -21.46%-5.23M-64.34%-7.83M50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M
Diluted earnings per share 0.00%-0.07-37.50%-0.1150.00%-0.042.56%-0.38-50.00%-0.15-16.67%-0.0738.46%-0.0827.27%-0.08-21.88%-0.39-11.11%-0.1
Basic earnings per share 0.00%-0.07-37.50%-0.1150.00%-0.042.56%-0.38-50.00%-0.15-16.67%-0.0738.46%-0.0827.27%-0.08-21.88%-0.39-11.11%-0.1
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data